|
1
|
Fu DG: Epigenetic alterations in gastric
cancer (Review). Mol Med Rep. 12:3223–3230. 2015.PubMed/NCBI
|
|
2
|
Afuwape OO, Irabor DO, Ladipo JK and
Ayandipo B: A review of the current profile of gastric cancer
presentation in the university college hospital Ibadan, a tertiary
health care institution in the tropics. J Gastrointest Cancer.
43:177–180. 2012. View Article : Google Scholar
|
|
3
|
Tey J, Choo BA, Leong CN, Loy EY, Wong LC,
Lim K, Lu JJ and Koh WY: Clinical outcome of palliative
radiotherapy for locally advanced symptomatic gastric cancer in the
modern era. Medicine (Baltimore). 93:e1182014. View Article : Google Scholar
|
|
4
|
Katai H: Function-preserving surgery for
gastric cancer. Int J Clin Oncol. 11:357–366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ikeguchi M, Oka S, Gomyo Y, Tsujitani S,
Maeta M and Kaibara N: Prognostic benefit of extended radical
lymphadenectomy for patients with gastric cancer. Anticancer Res.
20:1285–1289. 2000.PubMed/NCBI
|
|
6
|
Jiang S, Ge W, Zheng L and Chen G:
Analysis of clinicopathological features and prognosis in 30 cases
with multifocal gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi.
18:135–138. 2015.In Chinese. PubMed/NCBI
|
|
7
|
Cui H, Deng J, Liang H, Zhang R, Ding X,
Pan Y, Wang B and Wu W: Advantage of D2+ lymph node dissection for
distal advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi.
18:127–130. 2015.In Chinese. PubMed/NCBI
|
|
8
|
Almubarak MM, Laé M, Cacheux W, de Cremoux
P, Pierga JY, Reyal F, Bennett SP, Falcou MC, Salmon RJ, Baranger B
and Mariani P: Gastric metastasis of breast cancer: A single centre
retrospective study. Dig Liver Dis. 43:823–827. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karagulle M, Fidan E, Kavgaci H and
Ozdemir F: The effects of environmental and dietary factors on the
development of gastric cancer. BUON. 19:1076–1082. 2014.
|
|
10
|
Lee YY and Derakhshan MH: Environmental
and lifestyle risk factors of gastric cancer. Arch Iran Med.
16:358–365. 2013.PubMed/NCBI
|
|
11
|
Zuk K, Peczek L, Stec-Michalska K, Medrek
M and Nawrot B: SATB1 expression in gastric mucosa in relation to
Helicobacter pylori infection and family history of gastric cancer.
Adv Med Sci. 57:237–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao Q, Wang Y, Cao Y, Chen A, Ren M, Ge
Y, Yu Z, Wan S, Hu A, Bo Q, et al: Potential health risks of heavy
metals in cultivated topsoil and grain, including correlations with
human primary liver, lung and gastric cancer, in Anhui province,
Eastern China. Sci Total Environ. 470–471:340–347. 2014. View Article : Google Scholar
|
|
13
|
Shin JY, Kim HS, Lee KS, Kim J, Park JB,
Won MH, Chae SW, Choi YH, Choi KC, Park YE and Lee JY: Mutation and
expression of the p27KIP1 and p57KIP2 genes in human gastric
cancer. Exp Mol Med. 32:79–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bretones G, Acosta JC, Caraballo JM,
Ferrándiz N, Gómez-Casares MT, Albajar M, Blanco R, Ruiz P, Hung
WC, Albero MP, et al: SKP2 oncogene is a direct MYC target gene and
MYC down-regulates p27 (KIP1) through SKP2 in human leukemia cells.
J Biol Chem. 286:9815–9825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cen B, Mahajan S, Zemskova M, Beharry Z,
Lin YW, Cramer SD, Lilly MB and Kraft AS: Regulation of Skp2 levels
by the Pim-1 protein kinase. J Biol Chem. 285:29128–29137. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang B, Ji LH, Liu W, Zhao G and Wu ZY:
Skp2-RNAi suppresses proliferation and migration of gallbladder
carcinoma cells by enhancing p27 expression. World J Gastroenterol.
19:4917–4924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsai YS, Lai CL, Lai CH, Chang KH, Wu K,
Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, et al: The role of
homeostatic regulation between tumor suppressor DAB2IP and
oncogenic Skp2 in prostate cancer growth. Oncotarget. 5:6425–6436.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang H, Song Y, Wu Y, Guo N, Ma Y and
Qian L: Erbin loss promotes cancer cell proliferation through
feedback activation of Akt-Skp2-p27 signaling. Biochem Biophys Res
Commun. 463:370–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ben-Izhak O, Akrish S, Gan S and Nagler
RM: Skp2 and salivary cancer. Cancer Biol Ther. 8:153–158. 2009.
View Article : Google Scholar
|
|
20
|
Li B, Lu W, Yang Q, Yu X, Matusik RJ and
Chen Z: Skp2 regulates androgen receptor through ubiquitin-mediated
degradation independent of Akt/mTOR pathways in prostate cancer.
Prostate. 74:421–432. 2014. View Article : Google Scholar
|
|
21
|
Davidovich S, Ben-Izhak O, Shapira M,
Futerman B and Hershko DD: Over-expression of Skp2 is associated
with resistance to preoperative doxorubicin-based chemotherapy in
primary breast cancer. Breast Cancer Res. 10:R632008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hao Z and Huang S: E3 ubiquitin ligase
Skp2 as an attractive target in cancer therapy. Front Biosci
(Landmark Ed). 20:474–490. 2015. View
Article : Google Scholar
|
|
23
|
Chan CH, Morrow JK, Zhang S and Lin HK:
Skp2: A dream target in the coming age of cancer therapy. Cell
Cycle. 13:679–680. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Orlans FB: Case studies of ethical
dilemmas: Animal Care and Use Committee. Lab Anim Sci. 7(Spec No):
59–64. 1987.
|
|
25
|
Rowan AN: Animals, science, and ethics -
Section IV. Ethical review and the animal care and use committee.
Hastings Cent Rep. 20:S19–24. 1990.PubMed/NCBI
|
|
26
|
Stockert JC, Blázquez-Castro A, Cañete M,
Horobin RW and Villanueva A: MTT assay for cell viability:
Intracellular localization of the formazan product is in lipid
droplets. Acta Histochem. 114:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yilmaz Z, Dogan AL, Ozdemir O and Serper
A: Evaluation of the cytotoxicity of different root canal sealers
on L929 cell line by MTT assay. Dent Mater J. 31:1028–1032. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu C, Macleod I and Su AI: BioGPS and
MyGene.info: Organizing online, gene-centric information. Nucleic
Acids Res. 41(Database Issue): D561–D565. 2013. View Article : Google Scholar :
|
|
29
|
Popiela T, Kulig J, Kolodziejczyk P and
Sierzega M; Polish Gastric cancer study group: Long-term results of
surgery for early gastric cancer. Br J Surg. 89:1035–1042. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fejzo MS, Anderson L, Chen HW, Anghel A,
Zhuo J, Anchoori R, Roden R and Slamon DJ: ADRM1-amplified
metastasis gene in gastric cancer. Genes Chromosomes Cancer.
2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei Z, Jiang X, Qiao H, Zhai B, Zhang L,
Zhang Q, Wu Y, Jiang H and Sun X: STAT3 interacts with Skp2/p27/p21
pathway to regulate the motility and invasion of gastric cancer
cells. Cellular Signal. 25:931–938. 2013. View Article : Google Scholar
|
|
32
|
Yoon JH, Seo HS, Choi WS, Kim O, Nam SW,
Lee JY and Park WS: Gastrokine 1 induces senescence and apoptosis
through regulating telomere length in gastric cancer. Oncotarget.
5:11695–11708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pavlides SC, Huang KT, Reid DA, Wu L,
Blank SV, Mittal K, Guo L, Rothenberg E, Rueda B, Cardozo T and
Gold LI: Inhibitors of SCF-Skp2/Cks1 E3 ligase block
estrogen-induced growth stimulation and degradation of nuclear
p27kip1: Therapeutic potential for endometrial cancer.
Endocrinology. 154:4030–4045. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pascal LE and Wang Z: Virtual drug design:
Skp1-Skp2 inhibition targets cancer stem cells. Asian J Androl.
15:717–718. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chan CH, Morrow JK, Li CF, Gao Y, Jin G,
Moten A, Stagg LJ, Ladbury JE, Cai Z, Xu D, et al: Pharmacological
inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem
cell traits and cancer progression. Cell. 154:556–568. 2013.
View Article : Google Scholar : PubMed/NCBI
|
